Spanish Red Biotech Pipeline

FUNDACIÓN JIMÉNEZ DÍAZ (Instituto de Investigación Sanitaria)

IN VIVO LENTIVIRAL GENE THERAPY FOR THE TREATMENT OF PRIMARY HYPEROXALURIA TYPE 1

Type: Others
Therapeutic area: Others
Indication: Researchers propose the use of LV based on the vector used for the treatment of Haemophilia B for the treatment of primary hyperoxaluria type 1
Phase: 1R+D
Studies location: Spain